Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 10:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 8,698 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Acquired Thrombotic Thrombocytopenic Purpura
Interventions: Caplacizumab, Standard of Care; Biological · Other
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 8
States / cities: St Louis, Missouri • Valhalla, New York • Durham, North Carolina + 5 more

Conditions: Glioblastoma
Interventions: MRI with Arterial Spin Labeling (ASL); Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Major Depressive Disorder
Interventions: NeuroStar TMS; Device
Lead sponsor: Neuronetics; Other
Eligibility: 18 Years to 70 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 6
States / cities: Chicago, Illinois • Baltimore, Maryland • Lincoln, Nebraska + 3 more

Conditions: Dravet Syndrome
Interventions: Clobazam, Placebo; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 1 Year to 16 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 8
States / cities: Los Angeles, California • Orlando, Florida • Rochester, Minnesota + 4 more

Conditions: Coronary Artery Disease (CAD), Coronary Calcification, Coronary Calcified Disease, Coronary Calcified Nodules
Interventions: Shockwave C2 Aero Coronary IVL System; Device
Lead sponsor: OPCI Core Laboratories LLC; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 8
States / cities: Thousand Oaks, California • Detroit, Michigan • Neptune City, New Jersey + 5 more

Conditions: Temperature
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 115 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Solid Tumors, Cancer
Interventions: Radiation Therapy; Radiation
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hepatitis C
Interventions: Hepatitis C Educational Brochure, Hepatitis C Educational Video; Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Buffalo, New York • Orchard Park, New York

Conditions: Embolic Stroke of Undetermined Source
Interventions: Not listed
Lead sponsor: Population Health Research Institute; Other
Eligibility: 21 Years to 50 Years
Enrollment: 535 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 7
States / cities: Stanford, California • Joliet, Illinois • Greensboro, North Carolina + 4 more

Conditions: Pancreatic Neoplasms
Interventions: RenovoCath™ R120 Catheter; Device
Lead sponsor: RenovoRx; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 5
States / cities: San Jose, California • Port Charlotte, Florida • Tampa, Florida + 2 more

Conditions: Bipolar 1 Disorder
Interventions: ELND005, Lamotrigine, Valproic acid, Placebo; Drug
Lead sponsor: OPKO Health, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 41
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 36 more

Conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis
Interventions: SpineLink® , SpineLink® II; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2009
U.S. locations: 2
States / cities: San Diego, California • Jacksonville, Florida

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Seizures, Metabolic Encephalopathy
Interventions: Transnasal Thermal Regulating Device; Device
Lead sponsor: CoolTech LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Lymphocytic Leukemia, Atrial Fibrillation, Hypertension, Cardiotoxicity
Interventions: no intervention; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoradionecrosis of the Jaw, Xerostomia
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Age-Related Atrophy
Interventions: AAM; Procedure
Lead sponsor: Musculoskeletal Transplant Foundation; Other
Eligibility: 30 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Boca Raton, Florida • Nashville, Tennessee • Dallas, Texas

Conditions: Analgesia, Postoperative Pain, Block
Interventions: Ropivacaine 0.5% Injectable Solution; Drug
Lead sponsor: Bruce Ben-David; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Wounds
Interventions: MIST Therapy, Vacuum Assisted Closure, MIST Therapy and Negative Pressure Wound Therapy; Device
Lead sponsor: Celleration, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Vitrectomy
Interventions: Vista Vitrectomy Probe; Device
Lead sponsor: VISTA Ophthalmics; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Los Angeles, California • Bradenton, Florida • Bala-Cynwyd, Pennsylvania + 1 more

Conditions: Coronary Artery Disease, Heart Valve Disease
Interventions: CDI 1000 COM and INVOS 5100; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Orange, California

Conditions: Pressure Ulcer
Interventions: Fluid Immersion Simulation System, Air Fluidized Bed System; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Non-erosive Reflux Disease
Interventions: Esomeprazole, Placebo; Drug
Lead sponsor: Midwest Biomedical Research; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Serious Bacterial Infection
Interventions: ATM-AVI, BAT; Combination Product · Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Myopia, Astigmatism
Interventions: Intralase IFS150, Visumax; Device
Lead sponsor: Edward E. Manche; Other
Eligibility: 21 Years to 60 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Palo Alto, California

Search by objective public record fields.

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease

UrbanHEAT: Health Behaviors, Outcomes, and Disparities in Individually Experienced Temperature Across an Urban Community

Prospective Patient Registry for Radiation Oncology Techniques and Quality

Hepatitis C-Video vs. Brochure Education Delivery

Young ESUS Patient Registry

Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder

Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability

Transnasal Induction of Normothermia for Neurogenic Fever

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study

Use of AAM for Correction of Age Related Volume Deficits in the Face

Volume vs Concentration: Quadratus Lumborum Blocks With High Volume/Low Concentration or Low Volume/ High Concentration in Nephrectomies

Comparative Effectiveness Study of MIST Therapy Versus Negative Pressure Wound Therapy

A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients

Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

A Comparison of LASIK Outcomes Using Two Femtosecond Lasers